This morning the Bionano Genomics (NASDAQ:BNGO) stock has emerged as an early winner and soared by 25% so far after the company announced Jason Friar as its new Chief Commercial Officer.
The announcement this morning has clearly been welcomed wholeheartedly by investors and it is easy to see why. Friar is a highly experienced executive and has excelled in the area of sales during the course of his illustrious career. In addition to that, Bionano also mentioned that he has the experience of scaling businesses successfully.
However, more importantly, he has considerably experience in the research and clinical markets related to cancers and genetic diseases. At Bionano, Friar is going to head the commercial teams and work towards bring in strong sales performance. In addition to that, Friar is also going to be involved in expanding the company’s market access by way of third party payors. Investors could do well to keep the stock in their watch lists today.
Market Action
As of 11:07, BNGO stock has soared by 22.30% to $8.41. The stock has seen huge volume with more than 43.55 million shares already traded, well above its 30-day average volume of 23.87 million. Over the past year, the stock has moved up 1176%. The stock is trading near to the oversold zone as RSI stands above 70.
 stock Moves Up Again: Break Out Ahead?){kind=link}